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/-region  genes regulate  immune responses  by two  interrelated processes:  (a)  by 
controlling the manner in which antigen is presented to antigen-specific helper and 
suppressor T  cells, and  (b)  by the production of antigen-specific T  cell factors that 
help or suppress the immune responses of other immunocompetent cells (1). Responses 
to the synthetic antigen poly(GluS°-Tyr  ~)  (GT) 1 are  controlled by genes of the I- 
region of the major histocompatibility complex (H-2)  of the mouse (2). Most strains 
of mice  have  been  shown  to  be  GT  nonresponders  (3).  This  is  not  a  result  of a 
generalized B cell defect, as all strains make a  very good antibody response to GT 
when it is coupled to the immunogenic carrier molecule methylated bovine serum 
albumin (GT-MBSA)  (3, 4). Nonresponder strains of mice can be classified as either 
GT-suppressor  strains  (H-2d'k'8),  in which GT-MBSA  antibody responses  are sup- 
pressed by prior injection with GT and GT-nonsuppressor strains (H-2~'b'q),  which 
lack this suppressive effect (3). GT-specific suppression is under the control of at least 
two immune suppressor (Is) genes, which we have tentatively mapped to the I-A and 
I-C  subregions  of the  H-2  complex  (4,  5).  GT-primed  suppressor  haplotype mice 
produce a  first-order T  cell-derived suppressor factor (TsF)  termed GT-TsFI which 
binds antigen, bears antigenic determinants of the I-J subregion, and functions largely 
by inducing, together with antigen, a second distinct subset of suppressor T  (Tsl)  cells 
(6-11). 
We have studied two GT-nonsuppressor mouse strains that differ in their genetic 
defects. Strain A mice (/-/-2  ~) lack the ability to produce GT-TsF1 after GT priming, 
however, they can generate Ts2 upon exposure to the appropriate GT-TsF1 (6, 8,  12). 
In contrast, C57BL/6 (B6, H-2 b) mice produce GT-TsF1 after GT priming, although 
they cannot be suppressed by this or any other first-order TsF  (6,  12). (B6  ×  A)F1 
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hybrid mice, because of complementation which circumvents parental genetic defects, 
is a  suppressor strain and can both produce and accept GT-TsF (12). 
In this paper we report that (nonsuppressor ×  nonsuppressor)F1 hybrid, (B6 ×  A)F1 
or  (BI0.GD  ×  B10.A)FI,  mice  produce  GT-TsF  of both  parental  I-J  types.  These 
factors were  isolated with  immunoadsorbent  columns constructed  with  monoclonal 
anti-I-J antibodies. The isolated factors were tested for their ability to induce Ts2 in 
vivo. We found that only one of the GT-specific factors produced by these F1 hybrid 
mice is able to stimulate the generation of Ts2. This not only demonstrates that these 
two factors are distinct both serologically and functionally, but also suggests, at least 
in  these complementing Fa hybrids, that  distinct  H-2-1inked genes may control the 
production of first- and second-order TsF. 
Materials  and  Methods 
Animals.  BALB/c mice  (H-2 d)  were purchased from Cumberland  View Farms, Clinton, 
TN.  (B6 ×  A)Fa and (B10.GD ×  B10.A)FI mice were bred in the animal facilities of Harvard 
Medical School, Boston, MA. C57BL/6, C57BL/10,  and A/J mice were obtained from The 
Jackson  Laboratory,  Bar  Harbor,  ME.  Mice  used  in  these  studies  were  2-4  mo  old  and 
maintained on standard laboratory chow and water ad libitum. 
Antigens.  GT  (lot 9; originally purchased from Miles Laboratories, Elkhart, IN) was the 
60  3O  1  generous gift of Dr. Baruj Benacerraf, Harvard Medical School. Poly(Glu  -Ala  -Tyr 0) (GAT) 
(lot 1), and MBSA were purchased from Vega Biochemicals, Tucson, AZ. GAT, GT, and their 
MBSA complexes were prepared as previously described (8). 
Antisera.  Anti-I-J  k alloantisera were prepared by injecting (DBA/2 ×  B10.A[3R])F~ mice 
every 2 wk with  107 B10.A(5R)  lymphoid cells. Likewise, anti-I-J  b alloantisera were prepared 
by injecting (DBA/2  X  B10.A[5R])F1 mice with B10.A(3R)  lymphoid cells. Recipient mice 
were bled after the 14th intraperitoneal injection. Monoelonal anti-I-J  b and anti-I-J  k antibodies 
were prepared as previously described (11). 
GT-TsF Preparation.  GT-TsF was  prepared as previously described (6,  12). Briefly, mice 
were primed with  100 pg GT in Maalox (aluminum-magnesium hydroxide gel; Wm. Rorer, 
Fort Washington, PA) intraperitoneally 3-5 d  before killing. Single cell suspensions of their 
spleens were prepared, adjusted to 6 ×  l0  s cells/ml in Hanks' balanced salt solution (HBSS) 
and sonicated at 50 W for 5 min by a Sonifier Cell Disrupter (Ultrasonic Industries, Westbury, 
NY) equipped with a microtip. Sonicated material was centrifuged at 40,000 g for 45 min at 
4°C, and the GT-TsF-containing supernatants were stored at -85°C until use. 
Immunoadsorbent  Columns.  Sera  and  monoclonal  antibodies  used  for  the  preparation  of 
immunoadsorbent  columns  were  heat-inactivated  for  30  rain  at  56°C.  Immunoadsorbent 
columns were prepared by coupling the immunoglobulin-rich fraction  (precipitated by 50% 
ammonium  sulfate,  dissolved, and  dialyzed against  0.5M  NaC1-0.1M  NaHCO3  buffer)  to 
cyanogen bromide (CNBr)-activated Sepharose 4B  (Pharmacia Fine Chemicals, Piscataway, 
N  J) at 2 mg protein/ml packed gel as previously described (11). In all cases, coupling efficiency 
of protein to  gel was  >90%.  Coupled  gels were  stored in  phosphate-buffered saline  (PBS) 
containing 0.02% NaN3 at 4°C until use. Immunoadsorbent columns were prepared by packing 
1 ml gel into a 3-ml syringe and exhaustively washing the column with PBS. "Crude" GT-TsF 
extract (0.1 ml, equivalent to 6 ×  107 lymphoid cells) was incubated on the get for 20 min at 
room temperature. The effluent was collected, the column was washed with 10 volumes of PBS, 
and  the bound  protein eluted with 0.I  M  glycine-HCl buffer, pH 2.5.  Eluted material was 
immediately neutralized to  pH  7.2  with  a  small quantity  of 2  M  Tris.  Concentrations  of 
adsorbed materials are expressed according to original concentrations of factors. 
Spleen Cell  Cultures.  Single cell suspensions of normal  BALB/c  (H-2 a)  spleen cells were 
aseptically prepared and washed once with HBSS. Cells were resuspended to a final concentra- 
tion of 16 ×  10  cells/ml in Mishell-Dutton medium (13) containing 10-  M 2-mercaptoethanol 
and  10% fetal calf serum (FCS; lot 2851,  Pel-Freez Biologicals, Rogers, AR) (11). 2.5 pg GT as 
GT-MBSA was added to wells of a multiwell culture plate (76-033-05;  Linbro Chemical Co., 
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was  added  to  cultures  at  final concentrations indicated  in  the  table  legends.  Cultures  were 
incubated for 5 d in a humidifed atmosphere of 83% N2,  10% CO2, and 7% 02 at 37°C. Cultures 
were fed daily with a  mixture of 50% nutritional cocktail and 50% FCS  (11). 
Induction of Ts2.  BALB/c mice were injected intravenously with 0.5 ml of immunoadsorbent- 
purified GT-TsF  (3  X  107 cell equivalents)  in the presence of a  small amount  (50 ng) of GT. 
The amount of GT added in all cases was at least 200 times less than the minimum tolerogenic 
dose of GT (9). 3 d  after the injection of factor, mice were killed, their spleens were aseptically 
removed,  single cell suspensions prepared,  and  1.5  X  106 of these "factor-primed" cells were 
added to fresh Mishell-Dutton cultures containing 6.5 X  106 syngeneic spleen cells. GT-MBSA 
(2.5/~g) was added to appropriate cultures and cells were incubated for 5 d  as described above. 
Hemolytic Plaque Assay.  Cultures were harvested 5 d  after initiation, cells were washed three 
times in HBSS, and plaque-forming cell (PFC) responses were assayed using sheep erythrocytes 
(SRBC) coupled with the cross-reacting polymer GAT (14). GT-specific PFC were determined 
by subtracting the number of PFC detected in the presence of suitable dilution of GAT from 
the number of PFC detected on GAT-SRBC in the absence of the specific inhibitor. All assays 
were performed in duplicate and the number of PFC per culture are reported. 
Results 
Analysis  of TsF Produced by  Parental and F1 Hybrid Mice.  GT-specific  immune sup- 
pression is controlled by at least two complementing Is genes (4, 5). GT-nonsuppressor 
strains can be divided into either of two categories  depending upon which Is  gene 
they lack. Table I summarizes the suppressive  characteristics of the parental and F1 
hybrid mice used in the present  studies.  H-2 b or 11-2 g2 haplotype mice cannot be 
suppressed  by  GT  preimmunization;  GT  injection  results  in  GT-specific  factor 
production, although these mice are not suppressed  by GT-specific  factors  derived 
from antigen-primed mice. On the contrary, 1t-2 a haplotype mice are unable to make 
GT-specific suppressor factors after GT injection, although they are readily suppressed 
by the appropriate GT-TsF. FI hybrid mice derived from the mating of the two types 
of nonsuppressor strains are readily suppressed by GT injection, with the concomitant 
production of GT-specific Ts and GT-TsF. 
(B6  ×  A)Ft Mice Produce Both I-J  k and I-J  b GT-TsF.  H-2  b (B6 and B 10) and H-2" 
(A/J and B10.A) mice are GT-nonsuppressor strains, although (B6 ×  A)F1 by virtue 
TABLE  I 
Summary of Suppressive Activities of Parental and Ft Hybrid Mice  Used in 
This Study* 
Sup- 
pressed by  Produce  Sup- 
Strain  H-2  GT pre-  GT-TsFI  pressed by 
immuni-  GT-TsF1 
zation 
C57BL/6 (B6)  b  -  +  - 
C57BL/10 (B10)  b  -  +  - 
D2.GD  g2  -  +  - 
A/J or BI0.A  a  -  -  + 
(B6xA)F1  b X a  +  +  + 
(BI0.C,D  X BI0.A)FI  g2  ×  a  +  +  + 
* Data  presented  in Table  I  have been published  (2  6),  or  in  the case of 
D2.GD,  were  previously unpublished. Extracts prepared from GT-primed 
D2.GD  mice suppressed the GT-MBSA  PFC  response  (3,585)  of BALB/c 
spleen cells  in  vitro at  l:200  ('<30),  1:400  (750),  and  1:800  (2,580)  final 
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of complementing Is genes derived  from the parental  strains  are suppressed  by GT 
preimmunization  (4,  5,  12).  We have also shown  that H-2  ~ mice can be suppressed 
by,  although  they  cannot  produce,  GT-TsF1,  indicating  that  they  lack  or  have 
impaired  Tsl  (6,  8,  12).  H-2  b  mice,  on  the  other  hand,  cannot  accept  GT-TsF1, 
although they readily produce GT-TsF upon GT injection, indicating that they lack 
a suitable target (i.e., pre-Ts2)  for GT-TsF1 (12).  (B6 ×  A)F1 mice, because the above- 
mentioned complementation of Is genes, can both produce and accept GT-TsF1 and 
hence are GT-suppressor mice (5,  12). In the present experiments, we confirmed these 
results  using  a  somewhat  different  assay scheme.  Thus  the  factors were  assayed  in 
vitro using allogeneic BALB/c responding cells (Table II). In addition, we asked the 
/-J-type of the resulting Ft GT-TsF. (B6 X A)F1 mice were injected with  100 #g of GT 
in  Maalox,  3  d  later  their  spleens  and  thymuses  were  removed,  and  GT-TsF  was 
extracted  from these tissues.  The F1 GT-TsF was sequentially  adsorbed on anti-I-J  k 
and  anti-I-J  b alloantisera  immunoadsorbent  columns.  The  data  shown  in  Table  II 
show that  (B6 ×  A)F1 GT-TsF suppresses  the GT-MBSA PFC responses of BALB/c 
mice in  vitro.  A  control extract  prepared  from Maalox-injected  (B6 X  A)F1 mice is 
not suppressive, but rather showed an enhancing effect. Adsorption of the F1 GT-TsF 
on  the  anti-I-J  k columns  shows  that  both  the  effluent  (material  not  bound  by the 
column) and the eluate of the column are suppressive. To gUard against the possibility 
that we had merely saturated the column, the effluent from the first (anti-I-J  k) column 
was passed over an anti-I-J  b immunoadsorbent.  It is apparent  from Table II that the 
effluent from the first (anti-I-J  k) column contains no detectable I-Jk-bearing material 
as the effluent from the anti-I-J  b column is totally nonsuppressive. On the other hand, 
the eluate from the anti-I-J  b column is suppressive, indicating that the bound material 
bears  I-J  b determinants.  Similarly,  the eluate  from the  first  anti-I-J  k column  is  not 
bound  by the anti-I-J  b column,  but  is  found in  the effluent  of this  second column. 
These data show that  (B6 X A)F1 mice produce both I-J  b and I-J  k GT-TsF. 
Sequential  Adsorption  of (B6  ×  A)F1  GT-TsF by  Monoclonal  Anti-I-J  k  and Anti-I-J b 
Immunoadsorbents.  Our  laboratory  has  recently  produced  monoclonal  antibodies  to 
TABLE II 
Mice Produce Both l-J  b and l-J  k GT-TsF  (B6 ×  A)FI 
Factor/fraction  Immunoadsorbent*  GT-specific PFC 
per culture~: 
--  --  945 
Control (B6 × A)F1 extract  --  1,230 
(B6 × A)F1 GT-TsF  --  548 
Effluent  Eluate 
(B6 X A)F1 GT-TsF  Alloanti-I-J  k  150§  61511 
Effluent alloanti-I-J  k  Alloanti-I-J  b  1,680  < 15 
Eluate alloanti-I-J  k  Alloanti-I-J  b  <15  1,185 
* Immunoadsorbent columns were constructed of anti-l-J b or anti-l-J k alloan- 
tisera coupled to CNBr-activated Sepharose as detailed in Materials and 
Methods. 
~: GT-specific PFC  responses to  2.5  #g  GT  as  GT=MBSA per  culture  of 
BALB/c spleen cells on day 5. 
§ Effluent alloanti-I-J  k. 
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1-ff  and  1-J  b  gene  products  (11).  Ig  fractions  of  the  ascites  fluids  from  anti-I-J 
hybridoma-bearing mice  were  coupled  to  CNBr-activated  Sepharose  4B  at  a  final 
protein concentration of 2  mg/ml. An extract derived from GT-primed (B6  ×  A)F1 
mice  (GT-TsF)  caused  nearly total  suppression of the GT-MBSA  PFC  response of 
BALB/c spleen cells in vitro (Table III). When  (B6 ×  A)Fx GT-TsF is passaged over 
a  monoclonal anti-I-J  k immunoadsorbent column (WF8.C 12.8) both the effluent and 
and eluate are suppressive.  Similar to the result seen  in Table II, the effluent  from 
this first column can be shown to contain an I-J  b GT-TsF, as is bound to and can be 
eluted from a monoclonal anti-I-J  b immunoadsorbent. Likewise, the acid eluate of the 
first anti-I-J  k column can be shown to contain I-J  k but not I-J  b GT-TsF, as none of its 
suppressive  activity  is  bound  by  WF9.20.8-Sepharose.  In  subsequent  studies,  the 
monoclonal  anti-I-J antibodies were  used  for the preparation  of immunoadsorbent 
columns, as they showed a  much clearer separation of I-J  b from I-J  k GT-TsF derived 
from these F1 mice. 
(BIO.GD  ×  BIO.A)F1  Mice Produce  both  I-J  k and I-J  b GT-TsF.  Mice of the H-2  gu 
(B 10.GD)  and H-2 a (B 10.A) haplotypes are not suppressed by GT preimmunization, 
although F1 mice derived from these haplotype are suppressed by GT  (4). As can be 
seen  from  Table  IV,  extracts  derived from  these  GT-primed  (B10.GD  ×  B10.A)F1 
mice are able to totally suppress the GT-MBSA responses of BALB/c spleen cells in 
vitro. Similar to our findings in Tables II and III, (B10.GD X  B10.A)FI mice produce 
both  an  I-J  b  and  an  I-J  k GT-TsF  as  a  consequence  of GT  priming.  Furthermore, 
Table V  indicates that the order of anti-I-J adsorption of the factors does not adversely 
affect the separation of the I-J  b and I-J  k GT-TsF. 
In addition, Table V  demonstrates  that  the I-J  b and I-J  k antigenic determinants 
are not found on the same molecule or molecular complex. The effluent, which is not 
bound by the WF8.C 12.8 immunoadsorbent (anti-I-Jk), is bound to and can be eluted 
from  WF9.40.5-Sepharose  (anti-I-jb).  Similarly,  when  (B10.GD  ×  B10.A)Fx  GT 
extract  is  adsorbed  by the  WF9.40.5  immunoadsorbent,  the effluent  contains I-J  k- 
bearing suppressor molecules.  From the above findings, we conclude that  both  (B6 
×  A)Fa and  (B10.GD  ×  B10.A)F1 hybrid mice produce both  I-J  b and  I-J  k GT-TsF 
after GT priming. Since the (B 10.GD ×  B 10.A)F1 hybrid mice should be homozygous 
TABLE  III 
Adsorption of (B6  X  A)Ft GT Extract by monoclonal Anti-I-J  k and Anti-I-J  b 
GT-specific PFC per 
Factor/fraction  Immunoadsorbent*  culture :~ 
--  --  555 
Control (B6 × A)F1 extract  --  890 
GT-primed (B6 × A)F1 extract  --  <10 
Effluent  Eluate 
GT-primed (B6 × A)  F2 Extract  WF8.C 12.8 (anti-I-J k)  < 10§  35[1 
Effluent WF8.Cl2.8  WF9.20.8 (anti-I-J b)  995  <10 
Eluate WF8.C 12.8  WF9.20.8 (anti-I-J b)  265  925 
* Immunoadsorbent  columns were constructed  of the Ig-containing  fractions of monoclonal anti-I-J  k or 
anti-I-J  b ascites fluids coupled to CNBr-activated  Sepharose as detailed in Materials and Methods. 
:~ GT-specific PFC responses to 2.5/tg GT as GT-MBSA per culture of BALB/c spleen cells on day 5. 
§ Effluent WF8.C12.8. 
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TABLE  IV 
Adsorption of (BIO.GD X  BIO.A)F1  GT-TsF by Monoclonal Anti-I-J k and Anti-l-J  b 
Factor/fraction  Immunoadsorbent*  GT-specific  PFC per 
cuhure~ 
--  --  580 
Control  (B10.GD  ×  B10.A)FI  --  1,037 
extract 
(B10.GD X BI0.A)F~ GT-extract  --  <10 
Effluent  Eluate 
(B 10.GD ×  B 10.A)F1 GT-extract  WF8.C 12.8 (anti-I-J  k)  < 10§  < 10ll 
Effluent  WF8.C12.8  WF9.40.5  (anti-I-J  b)  1,362  <10 
Eluate WF8.C12.8  WF9.40.5  (anti-I-J  b)  <10  1,132 
* Immunoadsorbent  columns were constructed from the Ig fractions  of monoclonal anti-I-J  k- or anti-l-J  h 
ascites coupled to CNBr-activated Sepharose  as detailed in the Materials and Methods. 
:~ GT-specific PFC responses to 2.5/tg GT as GT-MBSA per culture on day 5. 
§ Effluent  WF8.C12.8. 
II Eluate WF8.C12.8. 
TABLE  V 
b  k  I-J  and I-J  Antigenic Determinants Are Not Found on the Same Molecule 
Factor/fraction  Imnmnoadsorbent*  GT-specific PFC 
per cult ure:~ 
Control (BI0.GD ×  B 10.A)FI extract 
(B10.GD X BI0.A)F~ GT-extract 
(B 10,GD × B10.A)Fj GT-extract 
Effluent  WF8,C12.8 




Effluent  Eluate 
WF8.C12.8  (anti-l-J  k)  95§  170 
WF9.40.5  (anti-I-J  b)  640  60 
WF9.40.5  (anti-I-J  b)  201[  170 
WF8.C 12.8 (anti-I-J  k)  650  130 
* Immunoadsorbent columns were constructed of monoclonal anti-I-J  k or anti-I-j  b ascites coupled to CNBr- 
activated Sepharose  as detailed in the Materials and Methods. 
:~ GT-specific PFC response to 2.5 p,g GT as GT-MBSA per culture of BALB/c spleen cells on day 5. 
§ Effluent WF8.C12.8. 
I1 Effluent WF9.40.5. 
at  non-H-2-1inked  loci,  we  can  conclude  that  the  genes  responsible  for  Ts2  factor 
production  are controlled by the H-2 complex. 
Tse Induction  by 1-J  b but  Not by 1-J  k  GT-TsF Derived from  Ft Hybrid Mice.  We  have 
previously demonstrated  that  B6 GT-TsF  acts  by  inducing a  second  distinct  popula- 
tion of suppressor T  cells (Ts2)  (12).  The question then arises whether the I-J  b and  the 
I-J  k GT-TsFs derived from  (B6  ×  A)F1 or (B10.GD  ×  B10.A)F1 GT-primed  mice can 
both  induce  Ts2.  Sequentially  purified  I-J  b  or  I-J  k  GT-TsF  from  (B6  ×  A)F1  or 
(B10.GD  X  B10.A)F1  mice were injected  along with  50 ng GT  into  BALB/c  mice.  3 
d  later,  1.5  x  106  of these spleen  cells were added  to  6.5  X  106  fresh  BALB/c  spleen 
cells  and  cultured  for  5  d  in  the  presence  of GT-MBSA.  The  results  in  Table  VI 
clearly show  that  the  I-J  b and  I-J  k F1  GT-TsFs  from  both  hybrid  mice cause  >80% 
suppression  of the  GT-MBSA  PFC  response  of BALB/c  spleen  cells  when  added 
directly  to  Mishell-Dutton  cultures.  However,  when  we  assayed  the  ability  of these 
TsF to generate second-order Ts, only the I-Jb-bearing GT-TsF  is able to induce Ts2; H. Y,  LEI,  M.  E.  DORF,  AND C.  WALTENBAUGH  961 
TABLE VI 
I-J  b but Not I-J  k GT-TsF  from Ft Hybrid Mice Induces Ts2 in BALB/c Mice 
TsF added to culture or used to generate  Ts2 
cells* 
GT-specific PFC:~ when follow- 
ing materials were added to 
culture 
TsF§  Ts2 cells]l 
Experiment I 
None  1,345  1,033 
I-Jb-bearing (B6 X A)F1 GT-TsF  270 (80)¶  <10 (99) 
I-JLbearing (B6 X A)F2 GT-TsF  60 (96)  1,272 (0) 
Experiment II 
None  1,345  585 
I-Jb-bearing (B10.GD × B10.A)Fj GT-TsF  195 (86)  195 (67) 
I-Jk-bearing (B10.GD × B10.A)F1 GT-TsF  535 (60)  1,358 (0) 
*  GT-TsF was prepared from either (B6 X A)FI or (B10.GD X BI0.A)F1 mice as 
indicated,  l-Jb-bearing GT-TsF  was  prepared  from  the  effluent  anti-I-J  k 
(WF8.C12.8) then bound and eluted from anti-I-J  b (WF9.40.5) immunoadsorbents. 
Likewise, l-J~-bearing GT-TsF was prepared from the effluent of WF9,40.5 then 
bound and eluted from WF8.C 12.8 immunoadsorbents. 
:[: GT-specific PFC responses to 2.5 pg GT as GT-MBSA per culture of BALB/c spleen 
cells on day 5. 
§ Indicated GT-TsF added at 1:200 fnal dilution. 
[1 BALB/c mice were injected 3 d previously with 0.5 ml HBSS containing 3 ×  107 
cell equivalents  of indicated factor.  1.5  ×  106 "factor-primed"  spleen cells were 
added to 6.5 ×  10  e fresh BALB/c spleen cells as indicated. 
¶ Percent suppression is in parentheses. 
the I-Jk-bearing GT-TsF does not induce Ts2. From these data we must conclude that 
not  only are the I-J  b and  I-J  k GT-TsF distinct antigenically, but  they have distinct 
biological activities as well. 
B6 GT-TsF Generates GT-TsFe in A/J Mice.  The above data suggest that l-J  b and 
I-J  k GT-TsF produced by Fa hybrid mice may act at  different cellular levels. Since 
the  I-J  b  F1  GT-TsF  can  readily generate  Tsz,  whereas  I-J  k  Fa  GT-TsF cannot,  we 
asked whether I-J  b F1 GT-TsF acts by generating Tsz (i.e., it is a  GT-TsF1) and if the 
I-J  k  F1  GT-TsF  is produced  by Ts2  (and  hence  a  GT-TsF2).  Previous  experiments 
have shown that GT priming of A/J  (H-2 a) mice results neither in the generation of 
Ts nor in the production of GT-TsF. Therefore, B6 GT-TsF1 (extract from GT-primed 
B6  mice)  was  injected  intravenously  into  A/J  mice  in  the  absence  of additional 
antigen.  5  d  later an  extract  was  prepared  from  the spleens and  thymuses  of these 
"factor-primed"  mice.  Table  VII  shows  that  the  factor  derived  from  B6  GT-TsF- 
primed A/J mice (provisionally called GT-TsF2) can readily suppress the GT-MBSA 
response of BALB/c  mice in  vitro. That  GT-TsF2 is produced by the A/J  mouse is 
demonstrated by the fact that it is bound by a  monoclonal anti-I-J  k immunoasorbent 
column  (WF8.C12.8)  and  not  by  a  anti-I-J  b  immunoadsorbent  WF9.40.5),  which 
rules out contamination by B6 GT-TsF1. From these data we conclude that A/J mice, 
when  primed  with  B6  I-J  b  GT-TsF,  have  the  ability  to  produce  a  second-order 
suppressor factor (I-J  k GT-TsF2). 
Specificity of GT-TsFz.  Table VIII shows that I-J  k GT-TsF2 produced either in (B6 
×  A)Fa or (B 10.GD ×  B 10.A)Fx mice does not suppress the anti-SRBC PFC responses 
of BALB/c spleen cells in vitro. Likewise, the I-J  k GT-TsF2 produced in A/J  mice as 962  SUPPRESSOR  FACTORS  FROM  F~  ttYBRID  MICE 
TABLE  VII 
B6 GT-TsFI Generates GT-TsF2 in A/J Mice 
Factor*  Treatment~ 
GT-specific PFC per culture§ 
Experiment I  Experiment II 
None  --  788  510 
A/J GT-TsF2  --  < 15  160 
A/J GT-TsF2  Adsorbed WF8.C 12.8 (anti-I-J  k)  1,624  1,020 
A/J GT-TsF2  Acid eluate WF8.C12.8  <15  120 
A/J GT-TsF2  Adsorbed WF9.40.5  (anti-I-J  b)  <15  NTII 
A/J GT-TsFz  Acid eluate WF9.40.5  1,766  NT 
* A/J (I-J  k) mice were injected 3 d  previously with 0.5 ml of B6 (l-J  b) GT-TsF (3  X  107) cell equivalents. 
3 d later extracts were prepared from spleens and thymuses of these "factor-primed" mice. Extract  (A/J 
GT-TsF2) equivalent to 1.5 ×  106 lymphoid cells was added to indicated cultures. 
:~ Extracts from B6 GT-TsFl-primed A/J mice were adsorbed onto and eluted from indicated immunoad- 
sorbent columns as detailed in Materials and Methods. 
§ GT-specific PFC responses to 2.5/~g GT as GT-MBSA per culture of BALB/c spleen cells on day 5. 
H Not tested. 
TABLE  VIII 
Antigen Specificity  of l-J  ~ and l-J  b GT- TsF Derived from F1 Hybrid and 
A/J Mice 
GT-specific  SRBC- 
Factor/fraction*  PFC per  specific PFC 
culture~  per culture§ 
Experiment I 
Control GT-MBSA/SRBC response 
l-Jb-bearing (B6 ×  A)Fa GT-TsF1 
l-J*-bearing (B6 ×  A)F1 GT-TsF2 
1,010  2,100 
350  1,900 
<20  1,900 
Experiment II 
Control GT-MBSA/SRBC response 
A/J l-Jk-bearing GT-TsF2 
1,875  1,650 
<25  2,300 
* 1-J  b- and/-,]*-bearing (B6  x  A)F1 GT-TsF1 and GT-TsF2 were prepared by 
sequential adsorption as indicated in legend of Table VI and in Materials 
and Methods. A/J GT-TsF2 was extracted from the spleens and thymuses of 
B6 GT-TsFl-primed A/J mice as outlined in legend of Table VII. 
GT-specific  PFC  responses  to  2.5  #g  GT  as  GT-MBSA  per  culture  of 
BALB/c spleen cells on day 5. 
§ SRBC-specific PFC responses to 2 ×  10" SRBC per culture of BALB/c spleen 
cells on day 5. 
the  result  of B6  GT-TsF1  priming  does  not  suppress  the  anti-SRBC  response  in  a 
nonspecific manner. 
Discussion 
Genetic  defects  are useful  in  dissecting  T  cell  subsets involved in antigen-specific 
immune suppression.  Previous studies have shown a  heterogeneity in Is gene defects 
in  GT-nonsuppressor strains of mice  (2,  8,  12).  Strain  A  (H-2 a, l-J k)  mice lack the 
ability  to produce GT-TsF1,  but  can produce Ts2 upon exposure to the appropriate 
GT-TsF1.  In contrast, B6 or B 10 (H-2 b, [_jb)  mice readily produce GT-TsFa after GT 
injection,  although  they  lack  a  suitable  target  for  this  factor  (i.e.,  pre-Ts2).  Gene H.Y.  LEI, M.  E.  DORF, AND C. WALTENBAUGtt  963 
complementation between H-2 a  and  H-2 b or H-2 g2  nonsuppressor  parental  strains 
results in GT-suppressor F1 hybrid mice. In this paper we report that (nonsuppressor 
X nonsuppressor)Fa hybrid mice produce GT-TsFs of both parental haplotypes. Us- 
ing monoclonal anti-I-J antibodies that  display little or no cross-reactivity between 
the  I-J  ~  and  I-J  k  haplotypes  (11),  we  have  demonstrated  that  the  l-J  b  and  I-J  k 
antigenic determinants appear on different molecules or molecular complexes. The 
present  studies  show  that  only  the  I-J  b GT-TsF,  derived  from  (nonsuppressor  X 
nonsuppressor)F1 mice, is able to induce Ts2. This is consistent with the observation 
that  injection  of B6  [_jb  GT-TsF1  plus  50  ng  GT  into  A/J  mice  results  in  the 
production of an antigen-specific I-Jk-bearing GT-TsF2 (12).  The genetic control of 
GT-specific suppression has been shown to be under the control of two (or more) Is 
genes, tentatively mapped in the I-A  and I-C subregions of the H-2 complex (4, 5). 
Our present data demonstrate that GT-specific suppression is a result of the generation 
of two subsets of Ts and suggest that the genetic defects found in the H-2  ~ and H-2  b 
mice are at the level of Tsl and Ts2 (or Ts3) cells, respectively. 
The  failure to detect  I-Jk-bearing  TsF1  in  A/J,  B10.A,  or F1  mice derived from 
crosses involving these strains  (6,  12)  suggests that  there is  a  obligate defect in  the 
ability of these mice to produce GT-TsFl-inducing factor with I-J  k determinants. This 
implies that one site of Is gene action is at the Tsl cell or its factor. Furthermore, the 
present results suggest that the Is gene phenotype is dominant in F1 animals, thus (B6 
×  A)F1 or (B 10.A ×  B 10.GD)F1 hybrid mice, like the parental A/J and B 10.A strains, 
fail to produce an I-Jk-bearing, GT-specific TsFl-inducing factor. Is gene complemen- 
tation may occur through a different cellular mechanism than was previously observed 
for Ir gene complementation (15-17).  In the present system, complementation does 
not  restore the  ability to generate I-jk-bearing  TsF~-inducing factor, but  seems  to 
represent complementation of two distinct genetic defects, i.e., the ability to produce 
or accept TsFa. This is in sharp contrast to complementation for H-2-1inked Ir genes 
in which one observes restoration of a  common genetic defect in antigen-presenting 
cells  (17).  Furthermore,  in  accord  with  previous  suggestions  (2,  5,  12),  Is  gene 
complementation would require pairing of two distinct H-2-controlled defects involv- 
ing different cells required for immune suppression. Because it is postulated that both 
of these cellular defects are controlled by genes of the/-region, one must also postulate 
that GT-TsF1 which function in these F~ hybrids is not 1t-2 restricted. The ability of 
I-Jb-derived factors to suppress allogeneic BALB/c (H-2 a) GT-MBSA PFC responses 
supports this contention. 
Analysis of T  cell function has revealed that antigen-specific immunosuppression is 
mediated through the interaction of various subsets of suppressor T  cells  (Tsl, Ts2, 
Ts3)  and their factors (TsFI, TsF2, TsFa). First- and second-order suppressor factors 
have been reported for the nitrophenyl (NP), azobenzene arsonate (ABA), and keyhole 
limpet  hemocyanin  (KLH)  suppressor  systems  (18-20).  In  addition,  Ts3 cells  and 
factors have been described in  the  NP system. The I-Jb-bearing  GT-specific factor 
derived from F1 hybrid mice, in  the present study, resembles the GT-TsFa TsF1 as 
originally  defined  (8),  the  I-Jk-bearing  GT-TsF  appears  to  differ from  the  above 
reported factors in several important respects. The KLH-TsF3, ABA-TsF2, NP-TsF2 
and NP-TsF3 are H-2 restricted in their action. The I-Jk-bearing GT-TsF reported in 
the present study failed to show H-2 restriction as the suppressive activity was assayed 
in third-party BALB/c (H-2  a, I-J  a)  mice. The present data also indicate that Igh-V 964  SUPPRESSOR FACTORS FROM F1  HYBRID MICE 
gene restriction is not seen with either GT-TsF factor; in contrast, Igh restriction has 
been reported for the SRBC-, ABA-, KLH-, and  NP-antigen  systems  (18-21).  It  is 
important  to note that  the  lack of Vh  and H-2 restriction seen  in  the GT-antigen 
system may be a  result of how the factors are assayed.  By assaying TsF activity in 
allogeneic mice we would not detect H-2- or lgh-restricted factors. Presently, experi- 
ments are underway to detect additional GT-TsF which display such genetic restric- 
tions.  However, in the GT and GAT antigen systems, all strains of mice appear to 
produce a similar idiotype (22, 23) and, consequently, one may not be able to detect 
lgh  restriction  if the  idiotype is  nonpolymorphic. An  additional  reason  for lack of 
H-2 restriction in the GT system, may result from how the factors are prepared. In 
the present studies, mice were injected with GT 3-5 d  before factor preparation. In 
contrast, the ABA-factor is prepared 7 d after antigen injection (19), NP-TsF 7 d (18), 
and  the  KLH-TsF  is  prepared  2  wk  after  secondary  injection  with  KLH  (20). 
Differences in the interval between injection of antigen and extraction of factor may 
result  in  the  preparation  of TsF  from  animals  in  different  immunological  states. 
Different kinetic activities of Ts subsets would help explain why each antigen system 
would show different restrictions.  It may be that  the physiological state as well as 
genotype of the animal may influence which Ts subset(s) predominate after antigen 
injection, i.e., the longer the interval between antigen injection and factor preparation, 
the more restricted the suppression. 
The administration of microliter quantities of anti-I-J antibodies intravenously to 
mice has  been shown  to  augment  both  humoral  (24)  and  cellular  (25)  immunity, 
apparently through the inactivation of Ts. We have recently shown that some anti- 
I-J monoclonal antibodies can augment a  humoral immune response although they 
are unable to bind TsF (11). 1-J gene products have been shown to be expressed on 
helper T  (Th) cells and macrophage subsets as well as Ts (7, 26). Tada et al. (27) have 
shown  that  the 1-J  determinant  found  on  Th  is  distinct  from  that  found  on  Ts. 
Collectively, these results suggest a heterogeneity ofI-J gene products. Data presented 
in the present study suggest that there may be even more heterogeneity within the 1- 
j  subregion than has been heretofore reported with regard to 1-J expression on Ts (7). 
We have shown that the (nonsuppressor ×  nonsuppressor)F1 hybrid mice produce an 
I-J  b (and not an I-J  k)  GT-TsFx and an I-J  k (not an I-J  b)  GT-TsF2. In addition, we 
have looked for I-J  k GT-TsF1 in concentrations 10-fold greater than those used in the 
above studies and have seen no suppressive activity. There are several possibilities for 
this  finding;  first,  the  F1  hybrid  animal  may  make  GT-TsFs  of  both  parental 
haplotypes  in  quantitatively  different  amounts;  our  assay  may  only  detect  the 
predominant  one in  the  cell  extract.  We  have  produced  T  cell  hybridomas  from 
(nonsuppressor ×  nonsuppressor)F1 GT-primed mice and are currently exploring this 
possibility. The second possibility is that  I-J  b and  I-J  k gene products are allelically 
excluded on F1 cells and only Tsx and Ts2 cells of the appropriate 1-J phenotype are 
induced.  As  an  alternative,  only  I-J  b Tsa  and  I-J  k Ts2  are  detected  functionally, 
although  genotypically both  I-J  b and  I-J  k Tsl  and  Ts2 may be present.  The third 
possibility is that the I-J subregion may be comprised of multiple loci. Therefore, I-J  b 
Tsa  and  I-J  k Ts2 would  represent  separate  gene  products  from  different gene  loci 
located within the I-J subregion, each contributed the respective parental haplotype. 
This last possibility is most intriguing and would help explain the regulatory role for H.Y.  LEI, M.  E.  DORF, AND C. WALTENBAUGtt  965 
the I-J subregion and the selective expression I-J gene products on different subpop- 
ulations of regulatory T  cells and macrophages (20,  26, 27). 
Summary 
Antigen-specific suppression to poly(GluS°-Tyr  ~°)  (GT) is under the control of two 
complementary immune suppressor (Is) genes located in the major histocompatibility 
(H-2)  complex of the mouse.  Suppressor strains of mice produce both suppressor T 
(Ts) ceils and Ts-derived suppressor factors (TsF) that bear antigenic determinants of 
the  I-J  subregion  of the H-2  complex. Nonsuppressor strains of mice, on  the other 
hand, are not suppressed by GT preimmunization. These nonsuppressor mice, how- 
ever, can be classified according to those that lack the ability to make GT-specific T 
cell-derived suppressor factor (GT-TsF) after GT injection  (i.e., H-2 ~, l-J k mice) and 
those that lack the ability to be suppressed by the appropriate GT-TsF (i.e., H-2 b'g2, 
I-J  b mice). In the present study, we demonstrate that (H-2 a X  H-2b'g~)F1 hybrid mice 
produce  distinct  GT-specific  suppressor  factors  of  both  parental  l-J  haplotypes. 
Moreover, only the I-Jb-bearing GT-TsF derived from these Fa hybrid mice is able to 
induce second-order suppressor cells (Tsz). This is consistent with the observation that 
injection of GT-TsF1 derived from C57BL/6 (I-J b) mice into A/J (I-J k) mice leads to 
the production of an antigen-specific I-J  k GT-TsF2. Our results suggest that Is gene 
complementation occurs through a different cellular mechanism than was previously 
observed for Ir gene complementation. Further, we show that complementing (non- 
suppressor  X  nonsuppressor)F1  hybrid mice produce an l-J b (and not  an I-J  k)  GT- 
TsF1  and  an  I-J  k (not  an  I-J  b)  GT-TsF2, thus  suggesting  a  heterogeneity of Ia  loci 
within the I-J subregion. Data presented in the present study suggest that there may 
be even more heterogeneity within the I-J subregion than has been heretofore reported 
with regard to I-J expression on Ts. 
We thank Janice Price for excellent  technical assistance. 
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